Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Jul 15, 2024
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sana Biotechnology, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 6
| |||||||
Lyell Immunopharma, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 14
| |||||||
Prime Medicine, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 12
| |||||||
Rapport Therapeutics, Inc.
| 3.73M |
—
|
—
|
∞
| 3.73M |
Jun 10
| |||||||
Sana Biotechnology, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 6
| |||||||
Rapport Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Vir Biotechnology, Inc.
| 8K |
—
|
—
| +1.39% | 584.15K |
May 30
| |||||||
Boundless Bio, Inc.
| 2.63M |
$16.00 | $3,200,000.00 | +151.43% | 4.36M |
Apr 2
| |||||||
Boundless Bio, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Prime Medicine, Inc.
| 3.2M |
$6.25 | $20,000,000.00 |
∞
| 3.2M |
Feb 15
| |||||||
Sana Biotechnology, Inc.
| 1.82M |
$5.50 | $9,999,995.50 | +5.39% | 35.56M |
Feb 8
| |||||||
Neumora Therapeutics, Inc.
| 1.88M |
—
|
—
| +102.76% | 3.71M |
Dec 8
| |||||||
Neumora Therapeutics, Inc.
| 35.01K |
$11.77 | $412,139.61 | +0.85% | 4.13M |
Nov 13 - Nov 14
| |||||||
Neumora Therapeutics, Inc.
| 140.6K |
$10.98 | $1,543,563.42 | +3.55% | 4.1M |
Nov 8 - Nov 10
| |||||||
Neumora Therapeutics, Inc.
| 95.69K |
$11.49 | $1,099,944.70 | +2.48% | 3.96M |
Nov 3 - Nov 7
| |||||||
Neumora Therapeutics, Inc.
| 76.51K |
$13.68 | $1,046,848.16 | +2.02% | 3.86M |
Sep 28 - Sep 29
| |||||||
Neumora Therapeutics, Inc.
| 58.5K |
$11.97 | $700,464.24 | +1.57% | 3.78M |
Sep 26 - Sep 27
| |||||||
Neumora Therapeutics, Inc.
| 100.74K |
$11.19 | $1,127,063.95 | +2.78% | 3.72M |
Sep 22 - Sep 25
| |||||||
Neumora Therapeutics, Inc.
| 18.92M |
$17.00 |
—
| +178.19% | 29.55M |
Sep 19
| |||||||
Neumora Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Lyell Immunopharma, Inc.
|
0
|
—
|
—
|
—
|
0
|
Sep 8
| |||||||
Da32 Life Science Tech Acquisition Corp.
| -1.60M |
—
|
—
| -100.00% |
0
|
Jul 28
| |||||||
Lyell Immunopharma, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 16
| |||||||
Prime Medicine, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 14
| |||||||
Sana Biotechnology, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 8
| |||||||
Vir Biotechnology, Inc.
| 6.03K |
—
|
—
| +1.06% | 576.15K |
May 22
| |||||||
Sana Biotechnology, Inc.
| 536 |
—
|
—
| +65.61% | 1.35K |
Jan 5
| |||||||
Prime Medicine, Inc.
| 12.27M |
$17.00 |
—
|
∞
| 12.27M |
Oct 24
| |||||||
Prime Medicine, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Prime Medicine, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Sana Biotechnology, Inc.
| 321 |
—
|
—
| +64.72% | 817 |
Oct 5
| |||||||
Codiak Biosciences, Inc.
| 5M |
$1.50 | $7,500,000.00 | +129.73% | 8.85M |
Sep 13
| |||||||
Vir Biotechnology, Inc.
| -941.67K |
—
|
—
| -3.37% | 27.02M |
Sep 2 - Sep 6
| |||||||
Vir Biotechnology, Inc.
| -941.65K |
—
|
—
| -3.15% | 28.91M |
Aug 30 - Aug 31
| |||||||
Vir Biotechnology, Inc.
| -941.65K |
—
|
—
| -2.96% | 30.85M |
Aug 24 - Aug 25
| |||||||
Vir Biotechnology, Inc.
| -470.83K |
—
|
—
| -2.80% | 16.35M |
Aug 18
| |||||||
Vir Biotechnology, Inc.
| -1.41M |
—
|
—
| -2.69% | 51.19M |
Aug 12 - Aug 16
| |||||||
Sana Biotechnology, Inc.
| 266 |
—
|
—
| +115.65% | 496 |
Jul 5
| |||||||
Vir Biotechnology, Inc.
| -470.83K |
—
|
—
| -2.52% | 18.23M |
Jun 8
| |||||||
Lyell Immunopharma, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 8
| |||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. |
Want to view more results?
Unlock the hidden results with your Benzinga Account now. No purchase required.